Register Login
Register to leave comments
  • News bot Jan. 7, 2026, 1:58 p.m.

    📋 ORAMED PHARMACEUTICALS INC. (ORMP) - Clinical Trial Update

    Filing Date: 2026-01-07

    Accepted: 2026-01-07 08:56:12

    Event Type: Clinical Trial Update

    Event Details:

    Oramed Pharmaceuticals Inc. (ORMP) Announces Clinical Trial Update Oramed Pharmaceuticals Inc. (ORMP) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: scheduled, interest
    • Diseases/Conditions: Scilex products, January 26
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Regulatory Process
    • Collaboration: Scilex Holdings

    🔬 Clinical Development Pipeline (ORAMED PHARMACEUTICALS INC.):

    Product Type Development Stage Therapeutic Area Source
    Placebo OTHER Phase PHASE2 Diabetics ClinicalTrials.gov
    lipoic acid DRUG Phase PHASE2 Diabetics ClinicalTrials.gov
    Budesonide dry powder inhaler DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    ORMD 0801 DRUG Phase PHASE2 Brittle Type I Diabetes Mellitus ClinicalTrials.gov
    ORE1001 DRUG Phase PHASE1 Mild to Moderate Ulcerative Colitis ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Oramed Pharmaceuticals Inc.
    • CIK: 0001176309
    • Ticker Symbol: ORMP
    • Period End Date: 2026-01-07
    • Document Type: 8-K

Search

News categories